Phase 4 N=88 Monoamine Contributions to Neurocircuitry in Eating Disorders
Eating Disorder
Primary: 5-HT Transporter Binding as Measured During the PET Scan — 1.68; 1.54; 1.46; 1.60 binding potential (BPND) — p=> 0.05
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=73 Direct Application of Systane Complete to Contact Lenses
Dry Eye · Contact Lens Complication
Primary: Difference in Ocular Surface Damage as Measured by the Brien Holden Vision Institute (BHVI Grading Scale) at Two Weeks — 0.44; 1.08; 0.83 Score on a Scale — p=0.30
N/A N=36 Effectiveness of Taping on Anastomotic Regions in Patients With Breast Cancer-Related Lymphoedema
Breast Cancer Lymphedema · Compression Bandages · Manual Lymphatic Drainage
Primary: Change of the Limb Volume, (Last Value of the Follow-up - Baseline Value) — 160.01; 148.28 milliliter
N/A N=47 Yo Puedo! Diabetes Self-Management Education + mHealth in Mexico City
Type 2 Diabetes Mellitus
Primary: Change in Hemoglobin A1C From Baseline — -1.76; -0.97; 9.32; 9.09 percentage HbA1c — p=<0.15
Phase 1 N=12 GAD-Alum (Diamyd) Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes (DIAGNODE-1)
Diabetes Mellitus, Type 1
Primary: Number of Subjects With Injection Site Reactions Month 1 — 0; 0; 0; 1 Participants
Phase 4 N=287 Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children
Acute Respiratory Viral Infections
Primary: Time to Alleviation of All ARVI Symptoms. — 4.5; 5.2 days — p=0.026
Phase 2 N=30 Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption
Chronic Diarrhea · Irritable Bowel Syndrome With Diarrhea · Bile Acid Malabsorption
Primary: Total Fecal Bile Acid (BA) Excretion — 10.7; 3.6 μmoles/g — p=0.001
N/A N=48 Change in Skin Elasticity With RF and PEMF
Skin Abnormalities
Primary: Change in Facial Skin Elasticity — 0.7658; 0.7244 ratio
Phase 3 N=779 Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk
Hypercholesterolemia · Atherosclerotic Cardiovascular Disease
Primary: Percent Change From Baseline to Week 12 in Low-density Lipoprotein Cholesterol (LDL-C) — 2.35; -15.07 percent change — p=<0.001
N/A N=100 Perioperative Pain Management In Spine Surgery Patients: Part I
Pain
Primary: Immediate Postoperative Pain Control — 6.6; 6.8 score on a scale
Phase 2 N=134 Prophylactic Probiotics to Extremely Low Birth Weight Prematures
Feeding; Difficult, Newborn · Growth Failure · Necrotizing Enterocolitis
Primary: Time to Establish Full Enteral Feeds — 15; 15 days
Phase 1 N=32 A Study of LY900014 Formulation in Healthy Participants
Healthy
Primary: Pharmacokinetics (PK): Insulin Lispro Area Under the Concentration Curve From Time Zero to 8 Hours (AUC[0-8 Hours]) — 2050; 1930 Picomoles*hour/Liter (pmol*h/L)
Phase 3 N=214 Randomized Controlled Trial of Treatment of Male Partners of Women With BV
Recurrent Bacterial Vaginosis
Primary: Number of Female Partners Whose Male Partners Received Metronidazole Versus Females Whose Male Partners Did Not Receive Metrodiazole With Recurrence of BV in the Female…
Phase 3 N=251 Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity
Metabolism and Nutrition Disorder · Obesity
Primary: Change in BMI SDS (Week 0, Week 56) — -0.25; -0.02 SDS score — p=0.0022
N/A N=1,359 Greek NIS Spiolto ELLACTO
Pulmonary Disease, Chronic Obstructive
Primary: Percentage of Patients Achieving "Therapeutic Success" Defined as a ≥ 0.4 Point of Decrease in the Clinical COPD Questionnaire (CCQ) Score — 64.3 Percentage of…